Thomas C Ortmeier, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-829-2861 |
Dr. J Frederick Hall, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-829-2861 Fax: 218-828-7510 |
Dianne M. Kendall, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-829-2861 Fax: 218-828-7611 |
News Archive
People expect their medical needs to be satisfied when in the hospital, but how about their spiritual, emotional and cultural needs? These are also important to the healing process and, at Greenwich Hospital, it's the spiritual care chaplains who make sure doctors understand how to address these patient needs.
Although morphine is well known as a highly effective analgesic, its clinical utility is severely limited by the development of drug tolerance, the requirement for increasing doses to maintain analgesic effect, and the development of physical dependence.
A calmer and more considered approach to the safety of rosiglitazone (Avandia) - the GlaxoSmithKline treatment for type 2 diabetes - is needed to avoid unnecessary panic among patients, says an Editorial published online and in an upcoming edition of The Lancet.
Pharmasset, Inc. announced today the initiation of a Phase 2a trial investigating the combination of Pharmasset's PSI-7977, a nucleotide polymerase inhibitor, and BMS-790052, Bristol-Myers Squibb Company's NS5A replication complex inhibitor, for the treatment of chronic hepatitis C.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 7 days ago